-
Full-chain closed-loop development, with enneas anchored to the vision of becoming a global organic aloe vera full-industry-chain ecological platform.
2026-08-13Hainan Enneas has achieved vertical integration across the entire organic aloe vera industry chain, covering cultivation, production, R&D, and global trade. It has established a three-tiered, stable supply chain and built a global platform for organic aloe vera raw materials, serving the global health and beauty industry.
more -
Double organic + backed by global authoritative certifications, enneas aloe vera raw materials are exported to over 50 countries and regions worldwide.
2026-08-13Hainan Enneas boasts dual EU and USDA organic certifications, FSSC22000, and FDA compliance. Its aloe vera raw materials are exported to over 50 countries, with deep roots in the high-end European and American markets. It collaborates with German and U.S. organic biotech companies, offering both domestic and international supply channels.
more -
Mastering the core low-temperature drying patented process, Enneas uses its proprietary technology to lock in aloe vera’s high bioactivity.
2026-08-13Hainan Enneas’ proprietary VD™ ultra‑vacuum low‑temperature drying technology ensures rapid post‑harvest processing within 6 hours, locking in aloe’s bioactive compounds. Backed by the CNAS Aloe Research Center and HPLC‑based full‑process quality control, we supply a wide range of high‑activity aloe powders and gel‑juice raw materials.
more -
With 27 years of deep cultivation in the organic aloe vera industry chain, Hainan Enneas has built an integrated supply chain spanning from cultivation to finished-product raw materials.
2026-08-13Hainan Enneas, an organic aloe vera full-industry-chain manufacturer established in 2027, operates its own 3,000-mu organic base and a 30,000-㎡ GMP industrial park, with a production capacity of 10,000 tons. It offers end-to-end digital traceability and can handle both small and large batch orders for aloe vera raw materials, supplying food, cosmetics, and biopharmaceutical companies.
more
Contact Us
